Oppenheimer Asset Management’s Darling Ingredients DAR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.83M | Sell |
142,829
-3,350
| -2% | -$165K | 0.1% | 226 |
|
|
2025
Q4 | $5.26M | Sell |
146,179
-8,537
| -6% | -$289K | 0.06% | 289 |
|
|
2025
Q3 | $4.78M | Buy |
154,716
+16
| +0% | +$534 | 0.05% | 355 |
|
|
2025
Q2 | $5.87M | Buy |
154,700
+385
| +0.2% | +$12.7K | 0.07% | 310 |
|
|
2025
Q1 | $4.82M | Buy |
154,315
+19,113
| +14% | +$668K | 0.06% | 322 |
|
|
2024
Q4 | $4.55M | Sell |
135,202
-12,448
| -8% | -$471K | 0.06% | 338 |
|
|
2024
Q3 | $5.49M | Buy |
147,650
+24,435
| +20% | +$921K | 0.07% | 302 |
|
|
2024
Q2 | $4.53M | Buy |
123,215
+22,082
| +22% | +$916K | 0.06% | 329 |
|
|
2024
Q1 | $4.7M | Buy |
101,133
+3,956
| +4% | +$174K | 0.07% | 297 |
|
|
2023
Q4 | $4.84M | Sell |
97,177
-8,066
| -8% | -$366K | 0.07% | 308 |
|
|
2023
Q3 | $5.49M | Buy |
105,243
+191
| +0.2% | +$11.9K | 0.08% | 261 |
|
|
2023
Q2 | $6.7M | Buy |
105,052
+1,264
| +1% | +$77K | 0.1% | 236 |
|
|
2023
Q1 | $6.06M | Buy |
103,788
+5,993
| +6% | +$377K | 0.09% | 238 |
|
|
2022
Q4 | $6.12M | Sell |
97,795
-6,015
| -6% | -$424K | 0.1% | 229 |
|
|
2022
Q3 | $6.87M | Buy |
103,810
+2,516
| +2% | +$175K | 0.12% | 215 |
|
|
2022
Q2 | $6.06M | Sell |
101,294
-3,650
| -3% | -$277K | 0.1% | 225 |
|
|
2022
Q1 | $8.44M | Sell |
104,944
-2,813
| -3% | -$196K | 0.12% | 211 |
|
|
2021
Q4 | $7.47M | Buy |
107,757
+5,334
| +5% | +$388K | 0.1% | 233 |
|
|
2021
Q3 | $7.36M | Sell |
102,423
-4,620
| -4% | -$331K | 0.1% | 224 |
|
|
2021
Q2 | $7.23M | Sell |
107,043
-12,007
| -10% | -$846K | 0.1% | 234 |
|
|
2021
Q1 | $8.76M | Sell |
119,050
-1,252
| -1% | -$86K | 0.14% | 181 |
|
|
2020
Q4 | $6.94M | Sell |
120,302
-19,766
| -14% | -$945K | 0.12% | 207 |
|
|
2020
Q3 | $5.05M | Sell |
140,068
-24,007
| -15% | -$734K | 0.1% | 241 |
|
|
2020
Q2 | $4.04M | Sell |
164,075
-18,856
| -10% | -$411K | 0.08% | 273 |
|
|
2020
Q1 | $3.51M | Sell |
182,931
-19,667
| -10% | -$499K | 0.09% | 248 |
|
|
2019
Q4 | $5.69M | Sell |
202,598
-25,688
| -11% | -$573K | 0.12% | 205 |
|
|
2019
Q3 | $4.37M | Sell |
228,286
-14,563
| -6% | -$285K | 0.1% | 245 |
|
|
2019
Q2 | $4.83M | Sell |
242,849
-10,304
| -4% | -$211K | 0.11% | 235 |
|
|
2019
Q1 | $5.48M | Sell |
253,153
-16,370
| -6% | -$346K | 0.12% | 205 |
|
|
2018
Q4 | $5.19M | Sell |
269,523
-56,880
| -17% | -$1.15M | 0.13% | 191 |
|
|
2018
Q3 | $6.31M | Sell |
326,403
-61,886
| -16% | -$1.22M | 0.14% | 176 |
|
|
2018
Q2 | $7.72M | Sell |
388,289
-103,865
| -21% | -$1.88M | 0.19% | 137 |
|
|
2018
Q1 | $8.51M | Buy |
492,154
+5,745
| +1% | +$104K | 0.21% | 120 |
|
|
2017
Q4 | $8.52M | Hold |
486,409
| – | – | 0.23% | 118 |
|
|
2017
Q3 | $8.52M | Buy |
486,409
+53,716
| +12% | +$909K | 0.22% | 120 |
|
|
2017
Q2 | $6.81M | Buy |
432,693
+256
| +0.1% | +$3.96K | 0.19% | 136 |
|
|
2017
Q1 | $6.28M | Buy |
+432,437
| New | +$5.7M | 0.18% | 139 |
|
Other funds holding DAR
VPM
VCM
MIM
Oppenheimer Asset Management's DAR Position: Q1 2026 in Review
Oppenheimer Asset Management reduced its Darling Ingredients (DAR) stake by 2.3% in Q1 2026, selling an estimated $165K and leaving 142,829 shares worth $8.83M. The position accounts for 0.1% of the portfolio, ranked #226.
Oppenheimer Asset Management first reported a position in DAR in Q1 2017 and has held it in 37 quarters since. 608 funds tracked by Wall St. Rank hold DAR as of Q1 2026.
- Oppenheimer Asset Management held 142,829 shares of Darling Ingredients worth $8.83M as of Q1 2026.
- Oppenheimer Asset Management sold 3,350 Darling Ingredients shares in Q1 2026, an estimated $165K.
- Darling Ingredients made up 0.1% of Oppenheimer Asset Management's portfolio in Q1 2026, its #226 holding.
- Oppenheimer Asset Management first reported a position in Darling Ingredients in Q1 2017 and has held it in 37 quarters since.
- 608 funds tracked by Wall St. Rank held Darling Ingredients as of Q1 2026.
Based on Oppenheimer Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.